Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2005 1
2006 2
2007 3
2008 2
2009 4
2010 5
2011 6
2012 4
2013 8
2014 3
2015 4
2016 2
2017 1
2018 5
2019 7
2020 7
2021 7
2022 5
2023 5
2024 5
2025 7
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Loss of the extracellular protease ADAMTS1 reveals an antitumorigenic program involving the action of NIDOGEN-1 on macrophage polarization.
Caracuel-Peramos R, Rodríguez-Baena FJ, Redondo-García S, Villatoro-García JA, García-Muñoz A, Peris-Torres C, Plaza-Calonge MDC, Rubio-Gayarre A, López-Millán B, Ricciardelli C, Russell DL, Carmona-Sáez P, Rodríguez-Manzaneque JC. Caracuel-Peramos R, et al. Among authors: ricciardelli c. Oncoimmunology. 2025 Dec;14(1):2508057. doi: 10.1080/2162402X.2025.2508057. Epub 2025 May 22. Oncoimmunology. 2025. PMID: 40401531 Free PMC article.
Extracellular matrix of ovarian tumors.
Ricciardelli C, Rodgers RJ. Ricciardelli C, et al. Semin Reprod Med. 2006 Sep;24(4):270-82. doi: 10.1055/s-2006-948556. Semin Reprod Med. 2006. PMID: 16944424 Review.
Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination.
Fujimoto H, Yoshihara M, Rodgers R, Iyoshi S, Mogi K, Miyamoto E, Hayakawa S, Hayashi M, Nomura S, Kitami K, Uno K, Sugiyama M, Koya Y, Yamakita Y, Nawa A, Enomoto A, Ricciardelli C, Kajiyama H. Fujimoto H, et al. Among authors: ricciardelli c. Cancer Metastasis Rev. 2024 Sep;43(3):1037-1053. doi: 10.1007/s10555-024-10169-8. Epub 2024 Mar 28. Cancer Metastasis Rev. 2024. PMID: 38546906 Free PMC article. Review.
Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines.
Khetan R, Dharmayanti C, Gillam TA, Kübler E, Klingler-Hoffmann M, Ricciardelli C, Oehler MK, Blencowe A, Garg S, Albrecht H. Khetan R, et al. Among authors: ricciardelli c. Cancers (Basel). 2022 May 10;14(10):2362. doi: 10.3390/cancers14102362. Cancers (Basel). 2022. PMID: 35625966 Free PMC article. Review.
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7.
Bandara V, Foeng J, Gundsambuu B, Norton TS, Napoli S, McPeake DJ, Tyllis TS, Rohani-Rad E, Abbott C, Mills SJ, Tan LY, Thompson EJ, Willet VM, Nikitaras VJ, Zheng J, Comerford I, Johnson A, Coombs J, Oehler MK, Ricciardelli C, Cowin AJ, Bonder CS, Jensen M, Sadlon TJ, McColl SR, Barry SC. Bandara V, et al. Among authors: ricciardelli c. Nat Commun. 2023 Sep 8;14(1):5546. doi: 10.1038/s41467-023-41338-y. Nat Commun. 2023. PMID: 37684239 Free PMC article.
91 results